HIC1 is epigenetically silenced in many human cancers, including breast cancer, prostate cancer, colorectal cancer, liver cancer, and lung cancer (Chen et al., 2005; Cheng et al., 2014), and this is assumed to be ascribed to promoter hypermethylation. This evidence concerns the gene HIC1 and liver cancer.